Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences

By Laura M. Cox, S. Yamanishi, J. Sohn, A. Alekseyenko, J. M. Leung, Ilseung Cho, Sungheon Gene Kim, Huilin Li, Zhan Gao, D. Mahana and 5 more. Cell, 2014

1,716 citations recorded by the source corpus.

SUMMARY Acquisition of the intestinal microbiota begins at birth and a stable microbial community develops from a succession of key organisms. Disruption of the microbiota during maturation by low-dose antibiotic exposure can alter host metabolism and adiposity. We now show that low-dose penicillin (LDP), delivered from birth, induces metabolic alterations and affects ileal expression of genes involved in immunity. LDP that is limited to early life transiently perturbs the microbiota, which is sufficient to induce sustained effects on body composition, indicating that microbiota interactions in infancy may be critical determinants of long-term host metabolic effects. In addition, LDP enhances the effect of high-fat diet induced obesity. The growth promotion phenotype is transferrable to germ-free hosts by LDP-selected microbiota, showing that the altered microbiota, not antibiotics per se, play a causal role. These studies characterize important variables in early-life microbe-host metabolic interaction, and identify several taxa consistently linked with metabolic alterations.

Subfields: Genetics, Molecular Biology, Pediatrics, Perinatology and Child Health

View Paper: https://www.semanticscholar.org/paper/c8eaf896df2713a484768db17ee7f5cf14d739aa

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Genetics

In Molecular Biology

In Pediatrics, Perinatology and Child Health

Eric S. Lander

Citations in the corpus

The infant microbiome development: mom matters (2014, neutral): “Disruption of this normal assembly may have considerable downstream consequences for the development of autoimmune [4] and metabolic [5] pathologies.”
Antimicrobials and Antibiotic-Resistant Bacteria: A Risk to the Environment and to Public Health (2020, background): “Furthermore, such imbalances in the gut flora can dysregulate developme t of the immune system, which may affect adiposity a d bone gr wth; this is p r cularly unfavorable in the e rly years of life [31,32].”
The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota (2017, background): “antibiotic-modified microbiota, when transferred to germfree mice, was able to promote growth (335).”
Non-lethal inhibition of gut microbial trimethylamine production for the treatment of atherosclerosis (2015, background): “Nonetheless, the gut microbiome is known to be remarkably dynamic and adaptive, including changes in response to different dietary inputs, as well as the presence versus absence of distinct diseases (Cox et al., 2014; Koren et al., 2011; Wu et al., 2011).”
Impact of antibiotics on the human microbiome and consequences for host health (2022, background): “Antibiotics change the dominant members of the bacterial community which could have profound effects on immune development, metabolism, and growth of the infant (Cox et al., 2014; Nobel et al., 2015).”
Antibiotic use and its consequences for the normal microbiome (2016, background): “, biodiversity loss), leads to metabolic perturbations that affect adiposity and bone growth and alter normal immunologic development (6, 7).”
Natural history of the infant gut microbiome and impact of antibiotic treatments on strain-level diversity and stability (2015, background): “Subtherapeutic antibiotic doses lead to increased body mass in both farm animals (52) and laboratory mice (53).”
Partial restoration of the microbiota of cesarean-born infants via vaginal microbial transfer (2016, neutral): “Early interaction with commensal microbes is essential for healthy immune development and metabolic programming, and aberrant microbial colonization in newborns has been associated with long-term effects on host metabolism 3 or impaired immune development 2 .”
Intestinal barrier and gut microbiota: Shaping our immune responses throughout life (2017, background): “Low-dose penicillin in early life caused transient perturbations in the microbiota with persistent sustained metabolic alterations.(44) In addition, the presence of SFB has been linked to some autoinflammatory diseases, such as exacerbating autoimmune encephalitis and murine arthritis models.”
The composition of the gut microbiota throughout life, with an emphasis on early life (2015, background): “biota in early life (208), while the composition of the”